Fundz

Who to call at Aquestive Therapeutics, Inc., and when

Fundz watches for the moments Aquestive Therapeutics, Inc. starts buying, and tells you who to reach.

  • An alert the day Aquestive Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aquestive Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aquestive Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Aquestive Therapeutics Enters License Agreement with Eton Pharmaceuticals for LIBERVANT®

Oct 14, 2026

Contract Type

licensing

WarrenBiotechnologyHealthcareHealth CareMedicalTherapeuticsPharmaceuticalBiopharma

Description

On October 13, 2026, Aquestive Therapeutics, Inc. entered into a license agreement granting Eton Pharmaceuticals exclusive U.S. rights to commercialize LIBERVANT® buccal film for seizure clusters in epilepsy patients. The deal includes an upfront fee of $10.0 million and further milestone payments totaling up to $47.5 million

Quick answer

Aquestive Therapeutics Enters License Agreement with Eton Pharmaceuticals for LIBERVANT® (October 14, 2026). Aquestive Therapeutics, Inc. is based in Warren, New Jersey, United States.

What agreement did Aquestive Therapeutics, Inc. announce on October 14, 2026?
On October 13, 2026, Aquestive Therapeutics, Inc. entered into a license agreement granting Eton Pharmaceuticals exclusive U.S. rights to commercialize LIBERVANT® buccal film for seizure clusters in epilepsy patients.
What does Aquestive Therapeutics, Inc. do?
Aquestive Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs.
Where is Aquestive Therapeutics, Inc. based?
Aquestive Therapeutics, Inc. is based in Warren, New Jersey, United States.
Which similar companies announced agreements around the same time?
AbbVie Inc. (November 3, 2026), YD Bio Limited (October 20, 2026), Cognito Therapeutics (October 27, 2026) and Alexion (October 29, 2026) also announced agreements within 45 days of Aquestive Therapeutics, Inc.

Source: Fundz verified event record.

Other recent agreements in Healthcare and Medical

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Aquestive Therapeutics, Inc.

Location

30 TECHNOLOGY DRIVE SOUTH

Warren, New Jersey, United States

About

Aquestive Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with unmet medical needs. The company specializes in drug delivery technologies and is committed to improving patients' lives through its product pipeline. Their product candidate, Anaphylm™, aims to provide a new treatment option for severe allergic reactions. The company is headquartered in Warren, New Jersey.

Related People

Milosz
Senior decision-maker at this company
••••••••@••••••••

See Milosz's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Aquestive Therapeutics, Inc.'s next move

Learn about Strategic plan

Aquestive Therapeutics, Inc. signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.